Your browser doesn't support javascript.
loading
Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy.
Mansi, Elizabeth T; Johnson, Eric S; Thorp, Micah L; Go, Alan S; Lee, Ming-Sum; Shen, Albert Yuh-Jer; Park, Ken J; Budzynska, Katarzyna; Markin, Abraham; Sung, Sue Hee; Thompson, Jamie H; Slaughter, Matthew T; Luong, Tiffany Q; An, Jaejin; Reynolds, Kristi; Roblin, Douglas W; Cassidy-Bushrow, Andrea E; Kuntz, Jennifer L; Schlienger, Raymond G; Behr, Sigrid; Smith, David H.
Affiliation
  • Mansi ET; School of Public Health, University of Washington, Seattle, Washington, USA.
  • Johnson ES; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Thorp ML; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Go AS; Department of Nephrology, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Lee MS; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Shen AY; Department of Cardiology, Los Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles, California, USA.
  • Park KJ; Department of Cardiology, Los Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles, California, USA.
  • Budzynska K; Department of Nephrology, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Markin A; Department of Family Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
  • Sung SH; Department of Emergency Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
  • Thompson JH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Slaughter MT; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Luong TQ; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • An J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Reynolds K; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Roblin DW; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Cassidy-Bushrow AE; Mid-Atlantic Permanente Research Institute, Rockville, Maryland, USA.
  • Kuntz JL; Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.
  • Schlienger RG; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Behr S; Quantitative Safety and Epidemiology, Novartis Pharma AG, Basel, Switzerland.
  • Smith DH; Quantitative Safety and Epidemiology, Novartis Pharma AG, Basel, Switzerland.
Pharmacoepidemiol Drug Saf ; 30(12): 1630-1634, 2021 12.
Article in En | MEDLINE | ID: mdl-34558760
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Heart Failure / Angioedema Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Heart Failure / Angioedema Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Country of publication: